Van Eck Associates Corp Invitae Corp Transaction History
Van Eck Associates Corp
- $70.4 Billion
- Q2 2024
Shares
3 transactions
Others Institutions Holding NVTA
# of Institutions
38Shares Held
2.12MCall Options Held
0Put Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA1.28MShares$02.19% of portfolio
-
Alphabet Inc. Mountain View, CA236KShares$00.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ158KShares$00.0% of portfolio
-
Eaton Vance Management Boston, MA100KShares$00.0% of portfolio
-
Nelson, Van Denburg & Campbell Wealth Management Group, LLC Omaha, NE70KShares$00.0% of portfolio
About Invitae Corp
- Ticker NVTA
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 235,266,000
- Description
- Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...